Inhibrx Biosciences INBX
NASDAQ INBX
$101.53 -3.30 (-3.15%)
As of: Sep 30, 2026 · 1:51 PM EDT

Inhibrx Biosciences, Inc. (INBX) Net Margin (2023 - 2025)

Updated

Inhibrx Biosciences (INBX) recorded Net Margin of -10773.46% in FY2025, down 854559.46 percentage points from 843786.00% in FY2024.

Analysis

Inhibrx Biosciences, Inc. (INBX) Net Margin (2023 - 2025) Analysis & Trends

  • Per Business Quant data, INBX's Net Margin was 843786.00% in FY2024 (+857194.94 pp) and -13408.94% in FY2023.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -2,204.15%
Dec 31, 2024 -47,865.00%
Jun 30, 2024 1,858,011.00%
Dec 31, 2023 -5,728.52%
Sep 30, 2023 -43,520.17%
Jun 30, 2023 -156,840.00%
API Access

Inhibrx Biosciences, Inc. Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=INBX&period=max&api_key=YOUR_API_KEY